Eléments de l'association

	L. Provencher	3
	Triple Negative Breast Neoplasms (drug therapy)	2
	L. Provencher *Sauf* Triple Negative Breast Neoplasms (drug therapy)"	2
	Triple Negative Breast Neoplasms (drug therapy) *Sauf* L. Provencher"	1
	L. Provencher Et Triple Negative Breast Neoplasms (drug therapy)	1
	L. Provencher Ou Triple Negative Breast Neoplasms (drug therapy)	4
	*Corpus*	3114

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000275	R. Bell [Australie] ; J. Brown [Royaume-Uni] ; M. Parmar [Royaume-Uni] ; M. Toi [Japon] ; T. Suter [Suisse] ; G G Steger [Autriche] ; X. Pivot [France] ; J. Mackey [Canada] ; C. Jackisch [Allemagne] ; R. Dent [Canada] ; P. Hall [Royaume-Uni] ; N. Xu [Suisse] ; L. Morales [Suisse] ; L. Provencher [Canada] ; R. Hegg [Brésil] ; L. Vanlemmens [France] ; A. Kirsch [Allemagne] ; A. Schneeweiss [Allemagne] ; N. Masuda [Japon] ; F. Overkamp [Allemagne] ; D. Cameron [Royaume-Uni]	Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024